Monitoring of phase transformations during processing of solid dosage forms

Pharmaceutical Technology Europe

Volumn 19, Issue 4, 2007, Pages 27-34

  Aaltonen, Jaakko ^a   Sandler, Niklas ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; EXCIPIENT; FLUFENAMIC ACID; NITROFURANTOIN; SUCCINIC ACID; THEOPHYLLINE;

ARTICLE; CALORIMETRY; CRYSTALLIZATION; DEHYDRATION; DISSOLUTION; DRUG BIOAVAILABILITY; DRUG DOSAGE FORM; DRUG GRANULATION; DRUG INDUSTRY; DRUG MANUFACTURE; FLUIDIZATION; FLUIDIZED BED; GRINDING; NEAR INFRARED SPECTROSCOPY; PHARMACY; PHASE TRANSITION; PROCESS MONITORING; QUANTITATIVE ANALYSIS; RAMAN SPECTROMETRY; SOLID; X RAY DIFFRACTION;

EID: 34248342128     PISSN: 01646826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. H.G. Brittain, J. Pharm. Sci., 91(7),1563-1570 (2002).
2. G.G.Z. Zhang et al., Adv. Drug Del. Rev., 56(3), 371-390 (2004).
3. Y. Hu et al., Ind. Eng. Chem. Res., 44(5), 1233-1240 (2005).
4. G. Févotte et al., Int. J. Pharm., 273(1-2), 159-169 (2004).
5. V. Chikhalia et al., Eur. J. Pharm. Sci., 27(1), 19-26 (2006).
6. L. Mackin et al., Int. J. Pharm., 231(2), 227-236 (2002).
7. M. Savolainen et al., J. Pharm. Pharmacol., 59(2), 161-170 (2007).
8. N. Sandler et al., AAPS PharmSciTech., 6(2), E174-183 (2005).
9. A. Jørgensen et al., Pharm. Res., 9(9), 1285-1291 (2002).
10. H. Wikström, P.J. Marsac and L.S. Taylor, J. Pharm. Sci., 54(1), 209-219 (2005).
11. J. Aaltonen et al., Chem. Eng. Sci., CES 62(1-2), 408-415.
12. J. Aaltonen, et al., J. Pharm. Sci., JPS 95(12), 730-2737.